Cargando…
Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study
BACKGROUND: Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute respiratory distress syndrome (ARDS) treated with either prophylactic or therapeutic dosage of heparin. All patients referre...
Autores principales: | Helms, Julie, Severac, François, Merdji, Hamid, Schenck, Maleka, Clere-Jehl, Raphaël, Baldacini, Mathieu, Ohana, Mickaël, Grunebaum, Lélia, Castelain, Vincent, Anglés-Cano, Eduardo, Sattler, Laurent, Meziani, Ferhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829649/ https://www.ncbi.nlm.nih.gov/pubmed/33492445 http://dx.doi.org/10.1186/s13613-021-00809-5 |
Ejemplares similares
-
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
por: Helms, Julie, et al.
Publicado: (2020) -
Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients
por: Helms, Julie, et al.
Publicado: (2020) -
Prothrombotic phenotype in COVID-19 severe patients
por: Helms, Julie, et al.
Publicado: (2020) -
Neurologic Features in Severe SARS-CoV-2 Infection
por: Helms, Julie, et al.
Publicado: (2020) -
Performances of disseminated intravascular coagulation scoring systems in septic shock patients
por: Helms, Julie, et al.
Publicado: (2020)